ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 98 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$38,271
+4.4%
2,473,910
+6.0%
0.05%
+2.2%
Q2 2023$36,670
+110.5%
2,334,195
+120.8%
0.04%
+95.7%
Q1 2023$17,424
-71.4%
1,057,275
-72.9%
0.02%
-72.9%
Q4 2022$60,907
-99.7%
3,904,296
+171.3%
0.08%
+203.6%
Q3 2022$18,665,000
+28.7%
1,439,118
+39.3%
0.03%
+33.3%
Q2 2022$14,505,000
+526.3%
1,033,086
+538.8%
0.02%
+600.0%
Q1 2022$2,316,000
+56.9%
161,713
+84.4%
0.00%
+50.0%
Q2 2021$1,476,000
-69.0%
87,700
-66.4%
0.00%
-66.7%
Q1 2021$4,768,000
+13.3%
261,131
+13.0%
0.01%0.0%
Q4 2020$4,207,000
-47.6%
231,178
-48.6%
0.01%
-53.8%
Q3 2020$8,023,000
-16.3%
449,745
-15.9%
0.01%
-27.8%
Q2 2020$9,585,000
+52.1%
534,578
+28.8%
0.02%0.0%
Q1 2020$6,300,000
+627.5%
415,001
+845.7%
0.02%
+800.0%
Q4 2019$866,000
-99.0%
43,883
-99.0%
0.00%
-99.0%
Q1 2019$85,973,000
+35.5%
4,220,584
+11.9%
0.20%
+22.3%
Q4 2018$63,449,0003,772,2450.17%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2018
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders